82
|
330
|
4y3fA |
Endothiapepsin in complex with fragment 78 |
85
|
330
|
4y5bA |
Endothiapepsin in complex with fragment 261 |
83
|
330
|
4y3wA |
Endothiapepsin in complex with fragment 35 |
85
|
330
|
4y4aA |
Endothiapepsin in complex with fragment 286 |
84
|
330
|
4y4zA |
Endothiapepsin in complex with fragment 73 |
86
|
330
|
4y3hA |
Endothiapepsin in complex with fragment 189 |
88
|
330
|
4y51A |
Endothiapepsin in complex with fragment 52 |
81
|
330
|
4y38A |
Endothiapepsin in complex with fragment b29 |
86
|
330
|
4y3qA |
Endothiapepsin in complex with fragment 109 |
79
|
330
|
4y3sA |
Endothiapepsin in complex with fragment 266 |
84
|
330
|
4y4bA |
Endothiapepsin in complex with fragment 323 |
91
|
339
|
4xx4A |
Renin in complex with (4s)-4-isopropyl-4-methyl-6-oxo-1-(3-(2-oxo-4-phenylpyrrolidin-1-yl)benzyl)tetrahydropyrimidin-2(1h)-iminium |
84
|
330
|
4y45A |
Endothiapepsin in complex with fragment 291 |
88
|
330
|
4y4xA |
Endothiapepsin in complex with fragment 51 |
83
|
330
|
4y3eA |
Endothiapepsin in complex with fragment 5 |
82
|
330
|
4y48A |
Endothiapepsin in complex with fragment b50 |
99
|
387
|
4xkxA |
Crystal structure of bace1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28 |
78
|
330
|
4y4gA |
Endothiapepsin in complex with fragment b53 |
84
|
330
|
4y4wA |
Endothiapepsin in complex with fragment 125 |
82
|
330
|
4y41A |
Endothiapepsin in complex with fragment 112 |
83
|
330
|
4y5eA |
Endothiapepsin in complex with fragment 268 |
85
|
330
|
4y3rA |
Endothiapepsin in complex with fragment 306 |
85
|
330
|
4y44A |
Endothiapepsin in complex with fragment 164 |
86
|
330
|
4y3pA |
Endothiapepsin in complex with fragment 17 |
78
|
330
|
4y4jA |
Endothiapepsin in complex with fragment b97 |
85
|
330
|
4y5kA |
Endothiapepsin in complex with fragment 274 |
84
|
330
|
4y5nA |
Endothiapepsin in complex with fragment 337 |
78
|
330
|
4y5lA |
Endothiapepsin in its apo form |
83
|
330
|
4y57A |
Endothiapepsin in complex with fragment 63 |
88
|
330
|
4y53A |
Endothiapepsin in complex with fragment 54 |
82
|
330
|
4y3dA |
Endothiapepsin in complex with fragment 321 |
85
|
330
|
4y3zA |
Endothiapepsin in complex with fragment 41 |
90
|
339
|
4xx3A |
Renin in complex with (s)-1-(3-(benzylcarbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1h)-iminium |
83
|
330
|
4y39A |
Endothiapepsin in complex with fragment 75 |
102
|
387
|
4wtuA |
Crystal structure of bace1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22 |
101
|
390
|
4x7iA |
Crystal structure of bace with amino thiazine inhibitor ly2886721 |
95
|
389
|
4wy6A |
Crystal structure of human bace-1 bound to compound 36 |
96
|
389
|
4x2lA |
Crystal structure of human bace-1 bound to compound 6 |
102
|
400
|
4wy1A |
Crystal structure of human bace-1 bound to compound 24b |
17
|
99
|
4upjA |
Human immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (k57l) complex with u097410 [4-hydroxy-3-[1-[3-[[[[(tert-butyloxycarbonyl) aminomethyl]carbonyl]amino]phenyl]propyl]coumarin |
18
|
99
|
4u7qA |
Structure of wild-type hiv protease in complex with photosensitive inhibitor pdi-6 |
105
|
400
|
4rroA |
8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors |
18
|
99
|
4u7vA |
Structure of wild-type hiv protease in complex with degraded photosensitive inhibitor |
16
|
99
|
4tvgA |
Hiv protease (pr) dimer in closed form with pepstatin in active site and fragment ak-2097 in the outside/top of flap |
98
|
387
|
4tryA |
Structure of bace1 complex with a hea-type inhibitor |
94
|
389
|
4trwA |
Structure of bace1 complex with a syn-hea-type inhibitor |
89
|
339
|
4rygA |
Renin in complexed with n-({(3s,4s)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3-methoxypropoxy)-n-(propan-2-yl)benzamide inhibitor |
18
|
99
|
4tvhA |
Hiv protease (pr) dimer in closed form with tl-3 in active site and fragment ak-2097 in the outside/top of flap |
78
|
388
|
4trzA |
Structure of bace1 complex with 2-thiophenyl hea-type inhibitor |
88
|
339
|
4rycA |
Renin in complexed with 4-methoxy-3-(3-methoxypropoxy)-n-{[(3s,4s)-4-{[(4-methylphenyl)sulfonyl]amino}pyrrolidin-3-yl]methyl}-n-(propan-2-yl)benzamide inhibitor |